Defining the biology component of the drug discovery strategy for malaria eradication.
about
The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugsKilling the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivaxNew developments in anti-malarial target candidate and product profilesMorphological and Molecular Descriptors of the Developmental Cycle of Babesia divergens Parasites in Human ErythrocytesCharacterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy ModelingSmall-molecule xenomycins inhibit all stages of the Plasmodium life cycleIdentification and deconvolution of cross-resistance signals from antimalarial compounds using multidrug-resistant Plasmodium falciparum strainsInterrogating alkyl and arylalkylpolyamino (bis)urea and (bis)thiourea isosteres as potent antimalarial chemotypes against multiple lifecycle forms of Plasmodium falciparum parasites.Luciferase-Based, High-Throughput Assay for Screening and Profiling Transmission-Blocking Compounds against Plasmodium falciparum Gametocytes.Role and Regulation of Glutathione Metabolism in Plasmodium falciparum.Resisting resistance: is there a solution for malaria?A validated bioluminescence-based assay for the rapid determination of the initial rate of kill for discovery antimalarials.Modelling the benefits of long-acting or transmission-blocking drugs for reducing Plasmodium falciparum transmission by case management or by mass treatment.Catechin Isolated from Garcinia celebica Leaves Inhibit Plasmodium falciparum Growth through the Induction of Oxidative Stress.Selective inhibition of PfA-M1, over PfA-M17, by an amino-benzosuberone derivative blocks malaria parasites development in vitro and in vivo.Antimalarial activity of novel 4-cyano-3-methylisoquinoline inhibitors against Plasmodium falciparum: design, synthesis and biological evaluation.Efficient Synthesis of 1,9-Substituted Benzo[h][1,6]naphthyridin-2(1H)-ones and Evaluation of their Plasmodium falciparum Gametocytocidal Activities.
P2860
Q26781634-CF456DDC-FF36-4E7A-A063-317A33214587Q28081463-9AF58649-6AAD-4007-A18B-5604CE5EB88EQ28468598-702C2BC6-7A77-4BC3-B5C6-27C630E7A1C5Q28547138-555CF338-3C7D-455A-9298-320BE05251F8Q28554466-57F4DB1F-2A60-43B5-9DFB-0F3BDE02A47FQ35076935-9266012E-C734-45B3-AB81-7307C237F3F8Q35106020-7CFF3EA8-1109-4C54-81BA-35E2C289F4D5Q35897525-4CE1D6C6-45DF-4A5C-B8F1-5C83FB54D299Q35898587-A7C3BB79-1749-4BF4-84C6-DA2BEE036675Q38523502-EBE8B6C9-EB09-4AAA-8054-1863A98537C3Q38755043-DEDA817C-ED32-4DCF-822B-6483C10615A4Q38780035-7E97B8D6-0C8B-4573-80ED-F54E470583AEQ40081071-FD7297D8-0C2C-4FB0-BA85-C5C1938794A5Q41197352-02D29FDE-292A-40F2-978F-B9D8BF342963Q41693109-CD0DE76F-70C8-42C6-992D-A79872DE0DE9Q41915260-BBF84E3F-E766-4814-A142-39310F380BB5Q48013081-BF7CC5F5-AAB3-4CE9-9178-EAB84FEEB381
P2860
Defining the biology component of the drug discovery strategy for malaria eradication.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Defining the biology component of the drug discovery strategy for malaria eradication.
@en
type
label
Defining the biology component of the drug discovery strategy for malaria eradication.
@en
prefLabel
Defining the biology component of the drug discovery strategy for malaria eradication.
@en
P2093
P356
P1476
Defining the biology component of the drug discovery strategy for malaria eradication.
@en
P2093
Brice Campo
Didier Leroy
Stéphanie Cherbuin
Xavier C Ding
P304
P356
10.1016/J.PT.2014.07.004
P577
2014-08-15T00:00:00Z